Inventor · disambiguated record
Derek V. Moe
Also filed as: MOE DEREK · MOE DEREK V
19 granted patents·19 pending applications·106 citations·filing 2004–2023
94Inventor score
Top patents by PatentIndex Score
38 records- 0196US11534409B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Dec 27, 2022·4 cites·19 claims
- 0294US11207318B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Dec 28, 2021·3 cites·14 claims
- 0394US9757371B2Immediate release abuse-deterrent granulated dosage formsCIMA LABS INC·Filed 2014·Granted Sep 12, 2017·18 cites·23 claims
- 0492US11730702B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Aug 22, 2023·2 cites·20 claims
- 0591US10888528B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jan 12, 2021·3 cites·19 claims
- 0691US10568881B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2018·Granted Feb 25, 2020·7 cites·23 claims
- 0791US10201505B2Immediate release abuse-deterrent granulated dosage formsCIMA LABS INC·Filed 2017·Granted Feb 12, 2019·8 cites·30 claims
- 0891US9827204B2Immediate release abuse-deterrent granulated dosage formsCIMA LABS INC·Filed 2016·Granted Nov 28, 2017·8 cites·33 claims
- 0990US9707224B2Immediate release abuse-deterrent granulated dosage formsCIMA LABS INC·Filed 2014·Granted Jul 18, 2017·9 cites·26 claims
- 1087US11324707B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2020·Granted May 10, 2022·3 cites·19 claims
- 1185US8119158B2Effervescent oral fentanyl dosage form and methods of administering fentanylMOE DEREK·Filed 2010·Granted Feb 21, 2012·7 cites·28 claims
- 1284US2023293445A1Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 1383US8298577B2Effervescent oral opiate dosage forms and methods of administering opiatesMOE DEREK·Filed 2010·Granted Oct 30, 2012·8 cites·10 claims
- 1480US11844796B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Dec 19, 2023·0 cites·17 claims
- 1579US7862833B2Effervescent oral opiate dosage forms and methods of administering opiatesCIMA LABS INC·Filed 2004·Granted Jan 4, 2011·12 cites·10 claims
- 1677US7858121B2Effervescent oral fentanyl dosage form and methods of administering fentanylCIMA LABS INC·Filed 2004·Granted Dec 28, 2010·6 cites·14 claims
- 1775US7862832B2Generally linear effervescent oral fentanyl dosage form and methods of administeringCIMA LABS INC·Filed 2004·Granted Jan 4, 2011·8 cites·7 claims
- 1870US11992468B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2023·Granted May 28, 2024·0 cites·8 claims
- 1968US2015050336A1Taste Masking System For Non-Plasticizing DrugsCIMA LABS INC·Filed 2014·Application pending·0 cites
- 2066US2015118295A1Immediate Release Abuse-Deterrent Granulated Dosage FormsCIMA LABS INC·Filed 2014·Application pending·0 cites
- 2166US2015118301A1Immediate Release Abuse-Deterrent Granulated Dosage FormsCIMA LABS INC·Filed 2014·Application pending·0 cites
- 2265US2008031949A1High dose orally dissolvable/disintegrable lyophilized dosage formCIMA LABS INC·Filed 2007·Application pending·0 cites
- 2365US2015118300A1Immediate Release Abuse-Deterrent Granulated Dosage FormsCIMA LABS INC·Filed 2014·Application pending·0 cites
- 2461US2008031947A1Orally dissolvable/disintegrable lyophilized dosage forms containing protectedCIMA LABS INC·Filed 2007·Application pending·0 cites
- 2560US2022105055A1Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 2657US2008069891A1Abuse resistant drug formulationCIMA LABS INC·Filed 2007·Application pending·0 cites
- 2757US2008031944A1Stabilization of lorazepamCIMA LABS INC·Filed 2007·Application pending·0 cites
- 2855US2022175766A1Compositions and methods of treatmentGB004 INC·Filed 2021·Application pending·0 cites
- 2954US2007036853A1Generally linear effervescent oral fentanyl dosage form and methods of administeringCIMA LABS INC·Filed 2006·Application pending·0 cites
- 3054US2006147516A1Taste masking system for alprazolamCIMA LABS INC·Filed 2006·Application pending·0 cites
- 3154US2016256392A1Abuse-deterrent dosage formsCIMA LABS INC·Filed 2014·Application pending·0 cites
- 3254US2006147517A1Taste masking system for non-plasticizing drugsCIMA LABS INC·Filed 2006·Application pending·0 cites
- 3353US2007048373A1Dried milled granulate and methodsCIMA LABS INC·Filed 2006·Application pending·0 cites
- 3450US9974751B2Abuse resistant drug formulationCIMA LABS INC·Filed 2012·Granted May 22, 2018·0 cites·6 claims
- 3548US2006062833A1Wound dressingCIMA LABS INC·Filed 2005·Application pending·0 cites
- 3644US8092832B2Generally linear effervescent oral fentanyl dosage form and methods of administeringMOE DEREK·Filed 2010·Granted Jan 10, 2012·0 cites·7 claims
- 3744US2017157052A1Immediate release dosage forms that deter abuse by oral ingestion of multiple dosage unitsCIMA LABS INC·Filed 2016·Application pending·0 cites
- 3844US2011200681A1Abuse Resistant Drug FormulationCIMA LABS INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Derek V. Moe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →